Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Ophthalmology

  Free Subscription


Articles published in Curr Opin Ophthalmol

Retrieve available abstracts of 107 articles:
HTML format



Single Articles


    September 2025
  1. NIELSEN CS, Soetikno BT, Pollreisz A, Ting DSW, et al
    Accelerating insight: the role of artificial intelligence in health economic analysis for ophthalmology.
    Curr Opin Ophthalmol. 2025 Sep 15. doi: 10.1097/ICU.0000000000001173.
    PubMed     Abstract available


  2. NATH S, Rahimy E, Kras A, Korot E, et al
    The utility of artificial intelligence in ophthalmic clinical trials.
    Curr Opin Ophthalmol. 2025 Sep 4. doi: 10.1097/ICU.0000000000001172.
    PubMed     Abstract available


  3. TAN TF, Thirunavukarasu AJ, Quek C, Ting DSW, et al
    Evaluation of ophthalmic large language models: quantitative vs. qualitative methods.
    Curr Opin Ophthalmol. 2025 Sep 4. doi: 10.1097/ICU.0000000000001171.
    PubMed     Abstract available


  4. SABAN O, Doan T, Seitzman GD
    COVID-19: ocular manifestations and associations with corneal transplant rejection and uveitis reactivation.
    Curr Opin Ophthalmol. 2025 Sep 4. doi: 10.1097/ICU.0000000000001165.
    PubMed     Abstract available


  5. MCNEELY RN, Moore JE, Mehta JS, Ting DSJ, et al
    Presbyopia-correcting intraocular lenses in eyes with corneal conditions: an update.
    Curr Opin Ophthalmol. 2025 Sep 4. doi: 10.1097/ICU.0000000000001175.
    PubMed     Abstract available


  6. ZHANG DL, Finn AP
    Glucagon-like peptide-1 receptor agonists and the eye.
    Curr Opin Ophthalmol. 2025;36:407-413.
    PubMed     Abstract available


  7. VAKHARIA P, Sridhar J
    Controversies in ophthalmology - challenges and crossroads in 2025.
    Curr Opin Ophthalmol. 2025;36:343-344.
    PubMed    


    August 2025
  8. TURNER ML, Nguyen MT
    Conjunctivitis secondary to novel systemic dermatologic agents: a growing concern.
    Curr Opin Ophthalmol. 2025 Aug 25. doi: 10.1097/ICU.0000000000001164.
    PubMed     Abstract available


  9. KASETTY VM, Grewal DS
    Considerations and surgical approach to vitreous, retinal, and chorioretinal biopsy.
    Curr Opin Ophthalmol. 2025 Aug 25. doi: 10.1097/ICU.0000000000001163.
    PubMed     Abstract available


  10. ELBASIONY E, Hu JCW, McKay KM, Sobrin L, et al
    Update on autoimmune retinopathy: diagnosis and management.
    Curr Opin Ophthalmol. 2025 Aug 25. doi: 10.1097/ICU.0000000000001162.
    PubMed     Abstract available


    July 2025
  11. ZHANG KX, Heisel CJ, Rahmani S
    Intravitreal antivascular endothelial growth factor therapy during pregnancy: an update and current perspective.
    Curr Opin Ophthalmol. 2025 Jul 3. doi: 10.1097/ICU.0000000000001160.
    PubMed     Abstract available


  12. PODD C, Fleifil S
    Advances in procedural management of dry eye disease.
    Curr Opin Ophthalmol. 2025;36:308-313.
    PubMed     Abstract available


  13. JIN K, Grzybowski A
    Advancements in artificial intelligence for the diagnosis and management of anterior segment diseases.
    Curr Opin Ophthalmol. 2025;36:335-342.
    PubMed     Abstract available


  14. AHLUWALIA A, Manche EE
    Comparing femtosecond LASIK and small-incision lenticule extraction (SMILE).
    Curr Opin Ophthalmol. 2025;36:276-281.
    PubMed     Abstract available


  15. AWAN R, Khan S, Khan WA
    Pediatric blepharokeratoconjunctivitis: review of epidemiology, pathophysiology, and current treatments.
    Curr Opin Ophthalmol. 2025;36:314-321.
    PubMed     Abstract available


    June 2025
  16. ZAIDI H, Vakharia PS
    The clinical importance of retinal displacement in planning retinal detachment repair and evaluating outcomes.
    Curr Opin Ophthalmol. 2025 Jun 23. doi: 10.1097/ICU.0000000000001156.
    PubMed     Abstract available


  17. RAMOS-DAVILA EM, Williams BK Jr, Di Nicola M
    Managing retinoblastoma in 2025.
    Curr Opin Ophthalmol. 2025 Jun 6. doi: 10.1097/ICU.0000000000001155.
    PubMed     Abstract available


  18. SAIGAL K, Shah S, Ansari Z
    Optometry co-management of preoperative and postoperative cataract surgery patients.
    Curr Opin Ophthalmol. 2025 Jun 6. doi: 10.1097/ICU.0000000000001153.
    PubMed     Abstract available


  19. TAN NRX, Chan KE, Lim BXH, Giannaccare G, et al
    Photobiomodulation: evidence and applications in ophthalmology.
    Curr Opin Ophthalmol. 2025 Jun 6. doi: 10.1097/ICU.0000000000001154.
    PubMed     Abstract available


    May 2025
  20. SAMUELSON AG, Patel SN, Garg SJ
    Management of endophthalmitis: to culture or not to culture?
    Curr Opin Ophthalmol. 2025 May 21. doi: 10.1097/ICU.0000000000001152.
    PubMed     Abstract available


  21. YUN JS, Santina A, Tseng VL
    Medical and surgical management of neovascular glaucoma.
    Curr Opin Ophthalmol. 2025 May 5. doi: 10.1097/ICU.0000000000001151.
    PubMed     Abstract available


  22. ABRAHAM JR, Talcott KE
    Approach and surgical management of epiretinal membrane.
    Curr Opin Ophthalmol. 2025;36:205-209.
    PubMed     Abstract available


  23. PARUCHURI SS, Mahmoudzadeh R, Wheeler S, Randolph J, et al
    Prevention and management of postcataract cystoid macular edema.
    Curr Opin Ophthalmol. 2025;36:182-188.
    PubMed     Abstract available


  24. STERKIN A, Yehezkel O
    Binocular treatment of amblyopia: current state and recent advances.
    Curr Opin Ophthalmol. 2025;36:237-246.
    PubMed     Abstract available


  25. SANCHEZ-SUAREZ J, Kim YJ, Miller WP, Kim LA, et al
    Recent advances in pharmacological treatments of proliferative vitreoretinopathy.
    Curr Opin Ophthalmol. 2025;36:253-261.
    PubMed     Abstract available


    April 2025
  26. GANNAMANENI K, Mian SI
    Corneal complications of common vaccinations.
    Curr Opin Ophthalmol. 2025 Apr 22. doi: 10.1097/ICU.0000000000001146.
    PubMed     Abstract available


  27. GINDINA S, Kang JJ, Jacobs DS
    Scleral lenses for correction of irregular astigmatism: advances and limitations.
    Curr Opin Ophthalmol. 2025 Apr 22. doi: 10.1097/ICU.0000000000001149.
    PubMed     Abstract available


  28. KHODOR A, Rodriguez-Gutierrez LA, Ruiz-Lozano RE, Perez VL, et al
    Updates in immunomodulator therapy in ocular surface inflammatory diseases.
    Curr Opin Ophthalmol. 2025 Apr 22. doi: 10.1097/ICU.0000000000001140.
    PubMed     Abstract available


  29. SINGH RB, Jhanji V
    Minimally invasive approaches to management of keratoconus.
    Curr Opin Ophthalmol. 2025 Apr 11. doi: 10.1097/ICU.0000000000001142.
    PubMed     Abstract available


  30. XU C, Xing B, Li JY
    Update in management of microbial keratitis associated with contact lenses.
    Curr Opin Ophthalmol. 2025 Apr 11. doi: 10.1097/ICU.0000000000001143.
    PubMed     Abstract available


  31. HUBSCHMAN S, Rosenblatt MI, Cortina MS
    Corneal neurotization for the treatment of neurotrophic keratopathy.
    Curr Opin Ophthalmol. 2025 Apr 10. doi: 10.1097/ICU.0000000000001138.
    PubMed     Abstract available


    March 2025
  32. CHAWLA K, Tailor PD, Sridhar J
    Evaluating the necessity of topical and subconjunctival antibiotic prophylaxis in ocular surgery.
    Curr Opin Ophthalmol. 2025 Mar 27. doi: 10.1097/ICU.0000000000001136.
    PubMed     Abstract available


  33. BOMMAKANTI N, Ni R, Kuriyan AE
    Treatment approaches for refractory full-thickness macular holes.
    Curr Opin Ophthalmol. 2025 Mar 7. doi: 10.1097/ICU.0000000000001131.
    PubMed     Abstract available


  34. SHAH P, Soundararajan S, Fleischman D
    Overlap syndrome: a case series and literature review of concurrent pigment dispersion and pseudoexfoliation syndromes.
    Curr Opin Ophthalmol. 2025;36:122-129.
    PubMed     Abstract available


    February 2025
  35. LIAO A, Fortes B, Au A, Hou K, et al
    Management of diabetic tractional retinal detachments: surgical experiences from a large tertiary academic institution.
    Curr Opin Ophthalmol. 2025 Feb 17. doi: 10.1097/ICU.0000000000001124.
    PubMed     Abstract available


  36. MISHRA AV, Loh GK, Ehmann DS
    Inpatient ophthalmology consultations for candidemia: a literature review and opinion.
    Curr Opin Ophthalmol. 2025 Feb 13. doi: 10.1097/ICU.0000000000001128.
    PubMed     Abstract available


  37. KALAVAR M, Sridhar J
    Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema.
    Curr Opin Ophthalmol. 2025 Feb 13. doi: 10.1097/ICU.0000000000001129.
    PubMed     Abstract available


  38. YOKOI T, Ni RL, Sivalingam MD, Yonekawa Y, et al
    Recent advancements in optic disc pit maculopathy management.
    Curr Opin Ophthalmol. 2025 Feb 13. doi: 10.1097/ICU.0000000000001130.
    PubMed     Abstract available


  39. LOVETT EA JR, Fan J, Williams BK Jr, Di Nicola M, et al
    Update on diagnosis and management of radiation retinopathy.
    Curr Opin Ophthalmol. 2025 Feb 11. doi: 10.1097/ICU.0000000000001126.
    PubMed     Abstract available


  40. PAN WW, Wubben TJ, Zacks DN
    Promising therapeutic targets for neuroprotection in retinal disease.
    Curr Opin Ophthalmol. 2025 Feb 11. doi: 10.1097/ICU.0000000000001123.
    PubMed     Abstract available


  41. DURRANI AF, Chaudhary V, Garg SJ
    Reducing Rates of Endophthalmitis from Intravitreal Injections - strategies and areas of controversy.
    Curr Opin Ophthalmol. 2025 Feb 6. doi: 10.1097/ICU.0000000000001120.
    PubMed     Abstract available


    January 2025
  42. MAI AP, Ferguson TJ, Radcliffe N
    New treatments for glaucoma.
    Curr Opin Ophthalmol. 2025 Jan 10. doi: 10.1097/ICU.0000000000001110.
    PubMed     Abstract available


  43. HASHEMI H, Fayaz F, Hashemi A, Khabazkhoob M, et al
    Global prevalence of cataract surgery.
    Curr Opin Ophthalmol. 2025;36:10-17.
    PubMed     Abstract available


  44. SIMON L, Murillo BA, Sabater AL
    A comprehensive update on over the counter artificial tears.
    Curr Opin Ophthalmol. 2025;36:76-82.
    PubMed     Abstract available


  45. FOUAD YA, Karimaghaei S, Elhusseiny AM, Alagorie AR, et al
    Pseudophakic cystoid macular edema.
    Curr Opin Ophthalmol. 2025;36:62-69.
    PubMed     Abstract available


  46. RAIMUNDO M, Findl O
    Update on intraocular lens formulas.
    Curr Opin Ophthalmol. 2025;36:4-9.
    PubMed     Abstract available


    December 2024
  47. KHAN MA
    Scleral fixated intraocular lens techniques for the vitreoretinal surgeon: an update.
    Curr Opin Ophthalmol. 2024 Dec 23. doi: 10.1097/ICU.0000000000001118.
    PubMed     Abstract available


  48. IWASE A, Araie M
    Implications of myopia in diagnosis and screening of open angle glaucoma.
    Curr Opin Ophthalmol. 2024 Dec 19. doi: 10.1097/ICU.0000000000001116.
    PubMed     Abstract available


  49. CHAN NS, Sng CCA
    Minimally invasive glaucoma surgery in angle closure.
    Curr Opin Ophthalmol. 2024 Dec 19. doi: 10.1097/ICU.0000000000001117.
    PubMed     Abstract available


    November 2024
  50. KHOSSRAVI AS, Chen Q, Adelman RA
    Artificial intelligence in ophthalmology.
    Curr Opin Ophthalmol. 2024 Nov 28. doi: 10.1097/ICU.0000000000001111.
    PubMed     Abstract available


  51. SHAH YS, Garg AK, Ramulu PY
    The effect of cataract surgery on lowering intraocular pressure.
    Curr Opin Ophthalmol. 2024 Nov 28. doi: 10.1097/ICU.0000000000001112.
    PubMed     Abstract available


  52. BARNA LE, Chung IY, Shen LQ
    Clinical pearls from glaucoma clinical trials: a case-based approach.
    Curr Opin Ophthalmol. 2024 Nov 21. doi: 10.1097/ICU.0000000000001113.
    PubMed    


  53. LOON SC, Ang BCH, White A
    Is minimally invasive glaucoma surgery killing trabeculectomies?
    Curr Opin Ophthalmol. 2024 Nov 14. doi: 10.1097/ICU.0000000000001108.
    PubMed     Abstract available


  54. LEE BJ, Jun JH, Afshari NA
    Challenges and outcomes of cataract surgery after vitrectomy.
    Curr Opin Ophthalmol. 2024 Nov 11. doi: 10.1097/ICU.0000000000001096.
    PubMed     Abstract available


  55. TORBEY J, Mansouri K
    Cataract surgery combined with glaucoma surgery.
    Curr Opin Ophthalmol. 2024 Nov 8. doi: 10.1097/ICU.0000000000001105.
    PubMed     Abstract available


  56. PALMER LD, Thompson AC, Asrani S
    Diagnosing glaucoma progression with optical coherence tomography.
    Curr Opin Ophthalmol. 2024 Nov 8. doi: 10.1097/ICU.0000000000001106.
    PubMed     Abstract available


  57. ENZENDORFER ML, Schmidt-Erfurth U
    Artificial intelligence for geographic atrophy: pearls and pitfalls.
    Curr Opin Ophthalmol. 2024;35:455-462.
    PubMed     Abstract available


    October 2024
  58. ANDRADE DE CARVALHO K, Esporcatte LPG, Gomes RLR, Ambrosio R Jr, et al
    Multimodal corneal imaging before refractive cataract surgery.
    Curr Opin Ophthalmol. 2024 Oct 30. doi: 10.1097/ICU.0000000000001102.
    PubMed     Abstract available


  59. GUTKIND NE, Gedde SJ
    Reporting outcomes of minimally invasive glaucoma surgery.
    Curr Opin Ophthalmol. 2024 Oct 29. doi: 10.1097/ICU.0000000000001100.
    PubMed     Abstract available


  60. ELHUSSEINY AM, Aref AA
    Lifestyle modifications and environmental risk factors for glaucoma.
    Curr Opin Ophthalmol. 2024 Oct 24. doi: 10.1097/ICU.0000000000001098.
    PubMed     Abstract available


  61. TAN TF, Quek C, Wong J, Ting DSW, et al
    A look at the emerging trends of large language models in ophthalmology.
    Curr Opin Ophthalmol. 2024 Oct 24. doi: 10.1097/ICU.0000000000001097.
    PubMed     Abstract available


  62. AHAD MA, AlHilali SM, Jomar DE
    Cataract surgery with endothelial keratoplasty.
    Curr Opin Ophthalmol. 2024 Oct 17. doi: 10.1097/ICU.0000000000001094.
    PubMed     Abstract available


  63. GRZYBOWSKI A, Auffarth GU, LaHood BR
    How do intraocular lens materials influence the outcome of cataract surgery?
    Curr Opin Ophthalmol. 2024 Oct 17. doi: 10.1097/ICU.0000000000001095.
    PubMed     Abstract available


    September 2024
  64. SEVGI M, Ruffell E, Antaki F, Chia MA, et al
    Foundation models in ophthalmology: opportunities and challenges.
    Curr Opin Ophthalmol. 2024 Sep 26. doi: 10.1097/ICU.0000000000001091.
    PubMed     Abstract available


  65. SHAH S, Chou B, Patel M, Watane A, et al
    Review and analysis of history and utilization of panretinal photocoagulation and ranibizumab after publication of protocol S.
    Curr Opin Ophthalmol. 2024;35:369-375.
    PubMed     Abstract available


  66. FINN AP, Sridhar J
    Challenges and controversies in ophthalmology in 2024.
    Curr Opin Ophthalmol. 2024;35:351-352.
    PubMed    


  67. ALEMAN AI, Kiryakoza L, Sridhar J, Sengillo J, et al
    Management of vitreous floaters: a review.
    Curr Opin Ophthalmol. 2024;35:365-368.
    PubMed     Abstract available


    August 2024
  68. PENNESI ME, Wang YZ, Birch DG
    Deep learning aided measurement of outer retinal layer metrics as biomarkers for inherited retinal degenerations: opportunities and challenges.
    Curr Opin Ophthalmol. 2024 Aug 29. doi: 10.1097/ICU.0000000000001088.
    PubMed     Abstract available


  69. RAMPAT R, Debellemaniere G, Gatinel D, Ting DSJ, et al
    Artificial intelligence applications in cataract and refractive surgeries.
    Curr Opin Ophthalmol. 2024 Aug 28. doi: 10.1097/ICU.0000000000001090.
    PubMed     Abstract available


  70. NG YIN LING C, Zhu X, Ang M
    Artificial intelligence in myopia in children: current trends and future directions.
    Curr Opin Ophthalmol. 2024 Aug 27. doi: 10.1097/ICU.0000000000001086.
    PubMed     Abstract available


  71. DOSSETT JP, Clavell CI, Ghorayeb G
    Ocular manifestations of West Nile virus.
    Curr Opin Ophthalmol. 2024 Aug 27. doi: 10.1097/ICU.0000000000001080.
    PubMed     Abstract available


  72. YANG Y, Chen X, Lin H
    Privacy preserving technology in ophthalmology.
    Curr Opin Ophthalmol. 2024 Aug 27. doi: 10.1097/ICU.0000000000001087.
    PubMed     Abstract available


  73. LIM G, Elangovan K, Jin L
    Vision language models in ophthalmology.
    Curr Opin Ophthalmol. 2024 Aug 27. doi: 10.1097/ICU.0000000000001089.
    PubMed     Abstract available


  74. VUJOSEVIC S, Limoli C, Nucci P
    Novel artificial intelligence for diabetic retinopathy and diabetic macular edema: what is new in 2024?
    Curr Opin Ophthalmol. 2024 Aug 27. doi: 10.1097/ICU.0000000000001084.
    PubMed     Abstract available


  75. KALAW FGP, Baxter SL
    Ethical considerations for large language models in ophthalmology.
    Curr Opin Ophthalmol. 2024 Aug 27. doi: 10.1097/ICU.0000000000001083.
    PubMed     Abstract available


  76. LEIDERMAN YI, Gerber MJ, Hubschman JP, Yi D, et al
    Artificial intelligence applications in ophthalmic surgery.
    Curr Opin Ophthalmol. 2024 Aug 15. doi: 10.1097/ICU.0000000000001033.
    PubMed     Abstract available


  77. PISITPAYAT P, Nijvipakul S, Jongkhajornpong P
    Ocular involvement in Steven-Johnson syndrome/toxic epidermal necrolysis: recent insights into pathophysiology, biomarkers, and therapeutic strategies.
    Curr Opin Ophthalmol. 2024 Aug 13. doi: 10.1097/ICU.0000000000001079.
    PubMed     Abstract available


    July 2024
  78. SHARMA A, Tijerina JD, Bitrian E
    Minimally invasive, maximally impactful: minimally invasive glaucoma surgery and the changing glaucoma landscape.
    Curr Opin Ophthalmol. 2024 Jul 30. doi: 10.1097/ICU.0000000000001077.
    PubMed     Abstract available


  79. DIONSON MM
    Immune recovery uveitis: an ocular manifestation in HIV/AIDS receiving treatment.
    Curr Opin Ophthalmol. 2024 Jul 17. doi: 10.1097/ICU.0000000000001078.
    PubMed     Abstract available


  80. ARMSTRONG GW, Liebman DL, Ashourizadeh H
    Implementation of anterior segment ophthalmic telemedicine.
    Curr Opin Ophthalmol. 2024;35:343-350.
    PubMed     Abstract available


  81. RANGU N, Dang DH, Riaz KM
    Current trends in the management of corneal neovascularization.
    Curr Opin Ophthalmol. 2024;35:329-342.
    PubMed     Abstract available


  82. GUPTA AS, Massaro M, Bunya VY
    Intense pulsed light treatment for the management of meibomian gland dysfunction.
    Curr Opin Ophthalmol. 2024;35:322-328.
    PubMed     Abstract available


  83. BONNET C, Gonzalez S, Deng SX
    Limbal stem cell therapy.
    Curr Opin Ophthalmol. 2024;35:309-314.
    PubMed     Abstract available


  84. KOO EH
    Current state of endothelial cell therapy.
    Curr Opin Ophthalmol. 2024;35:304-308.
    PubMed     Abstract available


    June 2024
  85. KAUFMAN R, Jun AS
    Emerging alternatives to keratoplasty for corneal endothelial cell dysfunction.
    Curr Opin Ophthalmol. 2024 Jun 27. doi: 10.1097/ICU.0000000000001071.
    PubMed     Abstract available


  86. LEE GG, Menean M, Williams BK Jr, Di Nicola M, et al
    Eco-sustainability in ophthalmology.
    Curr Opin Ophthalmol. 2024 Jun 25. doi: 10.1097/ICU.0000000000001070.
    PubMed     Abstract available


  87. NGUYEN R, Gomez-Castillo L, Gonzales JA
    Ocular manifestations of juvenile Sjogren's disease.
    Curr Opin Ophthalmol. 2024 Jun 25. doi: 10.1097/ICU.0000000000001069.
    PubMed     Abstract available


  88. WHEELER S, Mahmoudzadeh R, Randolph J
    Treatment for dry age-related macular degeneration: where we stand in 2024.
    Curr Opin Ophthalmol. 2024 Jun 14. doi: 10.1097/ICU.0000000000001064.
    PubMed     Abstract available


  89. CHEN JL, Al-Mohtaseb ZN, Chen AJ
    Criteria for premium intraocular lens patient selection.
    Curr Opin Ophthalmol. 2024 Jun 14. doi: 10.1097/ICU.0000000000001067.
    PubMed     Abstract available


  90. NGUYEN M, Doan T, Seitzman GD
    Ocular manifestations of mpox.
    Curr Opin Ophthalmol. 2024 Jun 7. doi: 10.1097/ICU.0000000000001066.
    PubMed     Abstract available


  91. WANG KY, Adams OE, Yu MD, Yonekawa Y, et al
    The necessity and role of scleral buckling for rhegmatogenous retinal detachment.
    Curr Opin Ophthalmol. 2024 Jun 3. doi: 10.1097/ICU.0000000000001065.
    PubMed     Abstract available


    May 2024
  92. MARSHALL RF, Xu H, Berkenstock M
    Ocular toxicities associated with antibody drug conjugates.
    Curr Opin Ophthalmol. 2024 May 31. doi: 10.1097/ICU.0000000000001063.
    PubMed     Abstract available


  93. TAILOR PD, D'Souza HS, Li H, Starr MR, et al
    Vision of the future: large language models in ophthalmology.
    Curr Opin Ophthalmol. 2024 May 31. doi: 10.1097/ICU.0000000000001062.
    PubMed     Abstract available


  94. ABING AA, Oh A, Ong LF, Marvasti AH, et al
    Surgical options and clinical outcomes for high myopia.
    Curr Opin Ophthalmol. 2024 May 2. doi: 10.1097/ICU.0000000000001053.
    PubMed     Abstract available


  95. MCENTIRE CRS, Chwalisz BK
    Cranial nerve involvement, visual complications and headache syndromes in Lyme disease.
    Curr Opin Ophthalmol. 2024;35:265-271.
    PubMed     Abstract available


  96. KURIYAN AE, Sridhar J
    The ever-evolving landscape of medical and surgical management of retinal disease.
    Curr Opin Ophthalmol. 2024;35:163-164.
    PubMed    


  97. TEO ZL, Ang M
    Femtosecond laser-assisted in situ keratomileusis versus small-incision lenticule extraction: current approach based on evidence.
    Curr Opin Ophthalmol. 2024 May 1. doi: 10.1097/ICU.0000000000001060.
    PubMed     Abstract available


  98. GREENSTEIN SA, Hersh PS
    Update on corneal crosslinking for keratoconus and corneal ectasia.
    Curr Opin Ophthalmol. 2024 May 1. doi: 10.1097/ICU.0000000000001056.
    PubMed     Abstract available


  99. KIM AJ, Shahraki K, Suh DW
    Pediatric refractive surgery: current opinion in ophthalmology.
    Curr Opin Ophthalmol. 2024 May 1. doi: 10.1097/ICU.0000000000001057.
    PubMed     Abstract available


    April 2024
  100. CEHELYK EK, Syed ZA
    Long-term outcomes of corneal crosslinking.
    Curr Opin Ophthalmol. 2024 Apr 29. doi: 10.1097/ICU.0000000000001054.
    PubMed     Abstract available


    March 2024
  101. PHILLIPS M, Chaudhary V
    Understanding network meta-analysis methodology for the ophthalmologist.
    Curr Opin Ophthalmol. 2024 Mar 15. doi: 10.1097/ICU.0000000000001048.
    PubMed     Abstract available


  102. HAMMELEF E, Rapuano CJ, Benedetto DA, Syed ZA, et al
    New forays into measurement of ocular biomechanics.
    Curr Opin Ophthalmol. 2024 Mar 14. doi: 10.1097/ICU.0000000000001032.
    PubMed     Abstract available


  103. GARG AK, Scott AW
    Systemic medications for sickle cell disease and potential applications for sickle cell retinopathy.
    Curr Opin Ophthalmol. 2024 Mar 11. doi: 10.1097/ICU.0000000000001041.
    PubMed     Abstract available


  104. BERKOWITZ ST, Finn AP
    Gene therapy for age-related macular degeneration: potential, feasibility, and pitfalls.
    Curr Opin Ophthalmol. 2024 Mar 5. doi: 10.1097/ICU.0000000000001043.
    PubMed     Abstract available


    February 2024
  105. KADONOSONO K, Inoue M, Yanagi Y
    Retinal arterial and vein occlusion: is surgery ever indicated?
    Curr Opin Ophthalmol. 2024 Feb 29. doi: 10.1097/ICU.0000000000001045.
    PubMed     Abstract available


  106. VAKHARIA P, Eichenbaum D
    Geographic atrophy: current and future therapeutic agents and practical considerations for retinal specialists.
    Curr Opin Ophthalmol. 2024 Feb 29. doi: 10.1097/ICU.0000000000001046.
    PubMed     Abstract available


    January 2024
  107. PATEL SB, Heier JS, Chaudhary V, Wykoff CC, et al
    Treatment of geographic atrophy: an update on data related to pegcetacoplan.
    Curr Opin Ophthalmol. 2024;35:64-72.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ophthalmology is free of charge.